Engineered proteins, and methods of making and using
The present invention provides engineered proteins and biomedical products made from the engineered proteins. The biomedical products include lenses useful for ophthalmic purposes.
1. A material for use in a mammalian eye, comprising:
a crosslinked elastin-mimetic peptide polymer comprising pentapeptide repeats having the sequence GXGXP (SEQ ID NO:35), wherein X is any natural, modified, or unusual amino acid, wherein the material is in a shape compatible with incorporation into the eye, biocompatible, transparent to visible light, has a refractive index compatible with vision by the eye, the material is permeable to sufficient nutrients to maintain eye tissue integrity upon incorporation into an eye, and wherein the material forms a hydrogel in water and has an elastic modulus in the hydrogel state of about 0.01 MPa to about 5.0 MPa.
2. The material of claim 1 , wherein the pentapeptide repeats are of an elastin domain.
3. The material of claim 2 , wherein the elastin domain comprises a sequence selected from the group consisting of SEQ ID NO: 2-4, 11, 12-20, functional variants having at least 80% sequence identity to one of SEQ ID NO: 2-4, 11, 12-20 and combinations thereof.
4. The material of claim 1 , 2 or 3 further comprising a sequence selected from the group consisting of SEQ ID NO: 21-23, 25 and combinations thereof.
5. A method of manufacturing a lens for incorporation into an eye, said method comprising the step of crosslinking an engineered polymer comprising pentapeptide repeats having the sequence GXGXP (SEQ ID NO: 35), wherein X is any natural, modified, or unusual amino acid, in a solution at a temperature below a lower critical solution temperature of the engineered polymer, thereby forming a hydrogel that is biocompatible, transparent to visible light, has a refractive index compatible with vision by the eye, has an elastic modulus of about 0.01 MPa to about 5.0 MPa, and has a shape compatible with incorporation into the eye.
6. The method of claim 5 , wherein the engineered polymer comprises repeated blocks of an elastin domain selected from the group consisting of SEQ ID NO: 2-4, 11, 12-19, or 20 or functional variants thereof having 80% sequence identity to one of SEQ ID NO: 2-4, 11, 12-19, or 20 and combinations thereof.
7. The method of claim 5 or 6 , further comprising the step of placing the solution into a mold to form a lens with a shape defined by the mold.
8. A material for use in a mammalian eye, comprising a crosslinked engineered protein which comprises repeated blocks of an elastin domain having one of SEQ ID NO: 2-4, 11, 12-19, and further comprises at least one fibronectin domain having one of SEQ ID NO: 26 and SEQ ID NO: 27, wherein the material is in a shape compatible with incorporation into the eye, biocompatible, transparent to visible light, has a refractive index compatible with vision by the eye, the material is permeable to sufficient nutrients to maintain eye tissue integrity upon incorporation into an eye, and wherein the material forms a hydrogel in water and has an elastic modulus in the hydrogel state of about 0.01 MPa to about 5.0 MPa.
9. A lens comprising a crosslinked engineered protein, which comprises repeated blocks of an elastin domain having the sequence of one of SEQ ID NO: 2-4, 11, 12-19, or 20 or functional variants thereof having 80% sequence identity to one of SEQ ID NO: 2-4, 11, 12-19, or 20, wherein the cross linked engineered protein comprises pentapeptide repeats having the sequence GXGXP (SEQ ID NO: 35), wherein X is any natural, modified, or unusual amino acid, and wherein the lens is optically transparent, resistant to biodegradation, biocompatible, and/or is in a shape suitable for incorporation into the eye.
10. A lens comprising a crosslinked engineered protein, which comprises repeated blocks of an elastin domain and at least one fibronectin domain,
wherein the elastin domain comprises a sequence of one of SEQ ID NO: 2-4, 11, 12-19, or 20 or functional variants thereof having 80% sequence identity to one of SEQ ID NO: 2-4, 11, 12-19, or 20; and
the at least one fibronectin domain comprises a sequence of one of SEQ ID NO: 26 or 27 or functional variants thereof having 80% sequence identity to one of SEQ ID NO: 26 or 27, and
wherein the at least one fibronectin domain further comprises a cell binding domain, and wherein the lens stimulates the adhesion of cells adjacent to said lens.
11. A method of modifying vision of a mammalian eye comprising the step of implanting (i) the lens of claim 9 or 10 , or (ii) the material of claim 1 , 2 or 3 , into a mammal in need thereof, to modify the vision of a mammalian eye.